Your SlideShare is downloading. ×
Conjunctiva 6
Conjunctiva 6
Conjunctiva 6
Conjunctiva 6
Conjunctiva 6
Conjunctiva 6
Conjunctiva 6
Conjunctiva 6
Conjunctiva 6
Conjunctiva 6
Conjunctiva 6
Conjunctiva 6
Conjunctiva 6
Conjunctiva 6
Conjunctiva 6
Conjunctiva 6
Conjunctiva 6
Conjunctiva 6
Conjunctiva 6
Conjunctiva 6
Conjunctiva 6
Conjunctiva 6
Conjunctiva 6
Conjunctiva 6
Conjunctiva 6
Conjunctiva 6
Conjunctiva 6
Conjunctiva 6
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Conjunctiva 6

1,344

Published on

Published in: Health & Medicine, Technology
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
1,344
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
34
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Pinguecula
    • Common, innocuous, bilateral, asymptomatic condition
    • Usually seen in elderly people, especially those exposed to strong sunlight, dust & wind.
    • Though yellow in color and looks like fat (hence the name, penguis meaning fat), it is due to hyaline infiltration and elastotic degeneration of the submucous connective tissue.
    • Signs :
    • Yellowish triangular patch of bulbar conjunctiva, near the limbus in the palpebral aperture, the apex of the traingle being away from the cornea.
    • Usually nasal side affected first, then temporal
    • Treatment : usually unnecessary because growth is very slow or absent. If acutely inflammed (pingueculitis) – short course of weak steroids (flourometholone)
  • 2. Pinguecula
  • 3. Pterygium
    • A pterygium is a triangular, wing shaped, fibrovascular subepithelial ingrowth of degenerative bulbar conjunctival tissue over the limbus onto the cornea ( pterygos - “wing”)
    • It is a degenerative condition of subconjunctival tissues which proliferate as a vascularized granulation tissue to invade the cornea, destroying the superficial layers of the stroma and Bowman’s membrane, the whole being covered by conjunctival epithelium
    • It is loosely adherent in its whole length to the underlying sclera, the area of adherence being always smaller than its breadth, so that there are folds at the upper and lower borders .
  • 4.  
  • 5. Pterygium
    • Etiology :
    • 1. Usually develop in patients who live in hot dry climates, high winds and abundance of dust.
    • 2. Exposure to ultraviolet light (UV type B)in solar radiation is most significant environmental factor.
    • - Involuntary partial closure of the interpalpebral fissure, mostly confined to the temporal side, to avoid glare from bright sunlight, may explain the predominance of pterygia on the nasal side.
    • 3. Genetic predisposition
    • 4. Pinguecula as a precursor of pterygium
  • 6. Pterygium
    • Histopathologically :
    • - it is a fibrovascular proliferation of conj tissue onto cornea
    • - it is hyperplasia, not dysplasia
    • - stains with elastic tissue stains, but unlike elastic tissue, it is not digested by elastase, hence termed elastotic degeneration.
    • - body of pterygium incorporates the underlying Tenon’s capsule, but not the episclera, hence it can be easily mobilized over the sclera
    • - at the limbus – no Tenon’s – hence adherent to episclera
    • - Head of the pterygium grows in a plane between Bowman’s layer and the basement membrane of corneal epithelium – Bowman’s membrane initially pushed posteriorly – later gets destroyed and pterygium tissue grows into stroma – pterygium becomes firmly adherent.
    • - primary pterygium are histopathologically different from recurrent pterygium : Recurrent pterygium is composed of only fibrovascular tissue, no elastotic degeneration, involves underlying episclera, sclera, rectus muscle sheath and corneal stroma and is firmly adherent to underlying structures throughout its extent, is highly vascularized.
  • 7. Pterygium
    • Clinical Features :
    • A small, grey, corneal opacity develops, near the nasal limbus.
    • The conjunctiva overgrows the opacity and progressively encroaches onto the cornea in a triangular fashion.
    • Anatomically divided into : head, neck and tail.
    • Head – part on the cornea
    • Neck – at the limbus
    • Tail – part on the sclera
    • A deposit of iron (Stocker line) may be seen in the corneal epithelium anterior to the advancing head of the pterygium in slow growing pterygiums, due to pooling of tears at the leading edge of pterygium
    • A probe can be slipped under the upper and lower folded borders of the body of the pterygium for a short extent and not across the entire breadth.
  • 8. Pterygium
    • Classification of pterygium :
    • Progressive Pterygium : actively growing, fleshy, vascular and inflamed – looking pterygium with no Stocker’s line
    • Stationary Pterygium : pterygium still looks vascular, but the head of the pterygium looks pale and sparsely vascularized and stops growing, develops a Stocker’s line
    • Regressive pterygium : pale, thin, papery, gray, anemic and membranous pterygium appears to be regressing, has a gray apex resembling corneal opacity
    • Nasal
    • Temporal
    • Double pterygia (both nasal and temporal)
    • Bilateral pterygia (both eyes)
    • Primary / Recurrent pterygium (regowth after excision)
  • 9. Pterygium
    • Treatment : surgical treatment is the only effective treatment for pterygium. However, none of the surgical procedures is perfect and universally accepted because of high recurrence rates.
    • Indications for surgery:
    • - primary indication is decreased visual acuity because of encroachment of the pterygium into visual axis or the irregular astigmatism induced by the growth.
    • - restricted ocular motility
    • - binocular diplopia
    • - ocular irritation and discomfort unresponsive to lubrication
    • - where pterygium restricts wearing of contact lenses
    • - difficulty in performing corneal refractive surgery
    • - cosmetic reasons
  • 10. Pterygium
  • 11. Pterygium
    • Current surgical procedures for pterygium treatment
    • Bare Sclera excision
    • Adjunctive use of Beta irradiation
    • Adjunctive use of Thiotepa
    • Adjunctive use of Mitomycin – C
    • Conjunctival transplantation / autograft
    • Limbal stem cell transplantation
    • Amniotic membrane allograft transplantation
  • 12. Pterygium
    • Bare sclera excision :
    • - surgical dissection of the pterygium starting from the head of the pterygium with lamellar keratectomy and extending to remove the body of the pterygium. The head, neck and body of pterygium are removed in one piece, leaving behind bare scleral area slightly more than the body of the removed pterygium. Hemostasis achieved using thermal cautery
    • - high rate of recurrence (23 – 75%)
  • 13. Pterygium
    • Beta irradiation :
    • - Standard Sr-90 applicator (dose : 1500 – 2500 reps) with shield
    • - expend most of their energy within superficial 2 mm of tissue
    • - irradiation induces obliterative endarteritis and arrest of fibroblast proliferation due to ionization changes in nucleus and cytoplasm of cells
    • - applied immediately after surgical excision of pterygium
    • - reduces recurrence rates to 0.5 – 16%
    • - limitations : requires trained radiologists / radiotherapists
    • - complications : cataract formation (dose related), dry eyes, corneal/ scleral thinning and ulceration
    • -
  • 14. Pterygium
    • Thiotepa :
    • - rarely used now
    • - nitrogen mustard family
    • - inhibits capillary endothelial proliferation, thereby inhibiting pterygium recurrence
    • - applied as topical drops
    • - poliosis, periorbital skin depigmentation, chronic conjunctivitis, scleral ulceration
  • 15. Pterygium
    • Mitomycin C
    • - antimetabolite agent
    • - selectively inhibits DNA replication, non-cell specific, action during late G1 and S phases of cell division
    • - intraoperative use of 0.02 – 0.05% (0.2 – 0.5 mg/dl) Mitomycin C for 30 sec – 3 min to bare sclera after pterygium excision
    • - reduces recurrence rate to 4 – 23 %
    • - postoperative use of mitomycin C topical drops (0.02%)
    • - complications : scleral thinning and perforation, corneal perforation, iritis, secondary glaucoma, cataract
  • 16. Pterygium
    • Conjunctival transplantation (conj autograft):
    • - conjunctival tissue taken from another site of same eye or other eye and grafted to pterygium excision site and sutured using vicryl/ nylon
    • - reduces recurrence rate to 5 – 7 %
    • - can be combined with intraoperative Mitomycin C application
  • 17. Pterygium
    • Limbal stem cell transplantation (autologous):
    • - healthy limbal epithelium acts as a junctional barrier to conjunctival cells migrating onto corneal surface.
    • - 0.5 mm of limbal/ peripheral corneal tissue is taken along with conjunctival autograft (Limbal conjunctival graft)
    • - graft placed with correct orientation on scleral recipient bed (corneal side towards cornea) and sutured using vicryl/nylon.
    • - recurrence rate 0 – 15%
    • - limitations : technically demanding, time consuming.
  • 18.  
  • 19. Pterygium
    • Amniotic membrane transplantation :
    • - amnion innermost layer of the placenta
    • - amniotic membrane separated from chorion, washed with antibiotics, and cut into small pieces and stored in Eagle’ medium at – 80 o C
    • - stroma of amniotic membrane suppresses proliferation and differentiation of fibroblasts
    • - recurrence rate of 10-16%
  • 20. Pterygium
  • 21. Pseudopterygium
    • Clinical features:
      • Adhesion of the conjunctiva to the peripheral cornea due to inflammatory causes, always stationary.
      • May occur on any quadrant of the cornea, at any age
      • Lacks firm adhesion throughout the underlying structures, and occasionally has a broad leading edge on the corneal surface, a probe can be passed under the neck
      • These findings differentiate it from true pterygium.
    • Pseudopterygium may result from a peripheral corneal ulcer and ocular surface inflammation such as cicatrizing conjunctivitis, chemical burns, or may also occur secondary to chronic mechanical irritation from contact lens movement associated with inadequate lubrication of the corneal surface.
  • 22. Dermoid, dermolipoma
    • Choristoma : congenital overgrowth of normal tissue in an abnormal location
    • They are not true neoplasms
    • Two main types : dermoid , dermolipoma
  • 23. Dermoid, dermolipoma
    • Dermoid :
    • May occur in isolation or often in patients with Goldenhar syndrome, Treacher Collins syndromes
    • Contain a variety of tissues such as cartilage, fat, muscle, hair follicles, sebaceous glands
    • Present in early childhood
    • Signs: smooth, soft, yellowish, subconjunctival masses most frequently located at inferotemporal limbus
    • Occasionally the lesion may encircle the limbus
    • Treatment : for cosmetic deformity, extends to visual axis, astigmatism – small lesions excised with or without lamellar corneal / scleral grafting
  • 24. Dermoid
  • 25. Dermoid, dermolipoma
    • Dermolipoma:
    • - fibrofatty tumours are congenital tumors consisting of fibrous tissue and fat, are not encapsulated
    • - more common in children
    • - signs : soft, movable, subconjunctival mass most commonly located at outer canthus
    • - treatment : should be avoided as surgery may be complicated by scarring, ptosis, dry eye and ocular motility problems. However, if they are particularly unsightly, then debulking the anterior portion.
  • 26. Dermolipoma
  • 27. Epithelioma (conj squamous cell carcinoma)
    • Rare, slow growing tumour of low-grade malignancy
    • May arise de novo or from preexisting carcinoma-in-situ
    • Seen with increased frequency in patients with xeroderma pigmentosum and AIDS
    • C/F: presents in late adult life with ocular irritation or mass
    • Signs : a fleshy pink, papillomatous or gelatinous mass, often associated with feeder vessels
    • Tumour most frequently juxtalimbal, seldom arising from fornices
    • May involve adjacent cornea, but deep scleral invasion is uncommon
    • Treatment :
    • - surgical excision with adjunctive chemotherapy
    • - topical chemotherapy with mitomycin C or 5-FU for recurrences
    • - Enucleation if intraocular invasion
    • - Exenteration if orbital invasion
  • 28. Epithelioma (conj squamous cell carcinoma)

×